News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fuhrman Alan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 05/25/2023 |
4
| Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,818 shares
@ $0
Granted 15,318 options to buy
@ $35.42, valued at
$542.6k
|
|
| 10/29/2021 |
4
| Fuhrman Alan (See Remarks) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Granted 246,671 options to buy
@ $3.93, valued at
$969.4k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 1,106 shares
@ $0
Granted 6,998 options to buy
@ $75.94, valued at
$531.4k
|
|
| 08/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/29/2020 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 1,221 shares
@ $0 |
|
| 05/22/2020 |
4
| Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 7,464 options to buy
@ $38.03, valued at
$283.9k
|
|
| 05/18/2020 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 11,003 shares
@ $0 |
|
| 03/18/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/16/2019 |
4
| Fuhrman Alan (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 29,983 options to buy
@ $18, valued at
$539.7k
|
|
| 09/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2018 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 8,750 options to buy
@ $180.98, valued at
$1.6M
|
|
| 06/11/2018 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 2,625 shares
@ $178.0711, valued at
$467.4k
Exercised 2,625 options to buy
@ $11.35, valued at
$29.8k
|
|
| 06/23/2017 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 11,000 options to buy
@ $78.58, valued at
$864.4k
|
|
| 06/13/2016 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 7,812 options to buy
@ $24.18, valued at
$188.9k
|
|
| 03/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/30/2015 |
4
| Fuhrman Alan (CFO) has filed a Form 4 on Mirna Therapeutics, Inc.|
Txns:
| Granted 167,180 options to buy
@ $7, valued at
$1.2M
|
|
| 07/30/2015 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 7,812 options to buy
@ $20.91, valued at
$163.3k
|
|
| 01/14/2015 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 15,625 options to buy
@ $11.35, valued at
$177.3k
|
|
| 11/12/2014 |
4
| Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP|
Txns:
| Disposed/sold 6,309 shares
@ $15, valued at
$94.6k
Disposed/sold 100,277 options to buy
@ $6, valued at
$601.7k
Disposed/sold 68,369 options to buy
@ $11.81, valued at
$807.4k
Disposed/sold 45,000 options to buy
@ $10.8, valued at
$486k
Disposed/sold 27,517 restricted stock units
@ $15, valued at
$412.8k
|
|
| 05/19/2014 |
4
| Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP|
Txns:
| Granted 27,517 restricted stock units
@ $0 |
|
| 01/10/2014 |
4
| Fuhrman Alan (CFO) has filed a Form 4 on AMBIT BIOSCIENCES CORP|
Txns:
| Granted 45,000 options to buy
@ $10.8, valued at
$486k
|
|
| 07/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|